SMOC1 and Alzheimer disease: Together, our findings provide new evidence about the important role of SMOC1 in AD and provide new context for why SMOC1 is consistently reported as a leading fluid biomarker for early AD in proteomic studies [44, 49–51, 87, 109, 116, 118, 128].